Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Nadavia Pharma ApS
APS
Dissolved
Reklamebeskyttelse
CVR 42878537
Granledet 6, 4600
Køge
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2021 · 4 years old
— employees
Overvåg
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
Nadavia Pharma ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
1M
1M
1M
0M
2022
EBITDA
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2022
Income statement
DKK thousands
Item
2022
Gross profit
-145
Staff expenses
-0
EBITDA
-145
Depreciation & amort.
-2
EBIT
-148
Net financials
-1
Profit before tax
-149
Tax
-32
Net profit
-117
Balance sheet
DKK thousands
Item
2022
Total assets
47
Equity
-77
Long-term debt
0
Short-term debt
123
Total debt
123
Financial ratios
5-year trend
EBITDA-margin (af bruttofortjeneste)
-14521900.0%
This company
2022
2022
Soliditetsgrad
-164.8%
This company
38.2%
Market median
-531% vs market
2022
2022
Egenkapitalforrentning
-11680000.0%
This company
18.4%
Market median
-63478361% vs market
2022
2022
Nettoresultatgrad (af bruttofortjeneste)
-11680000.0%
This company
2022
2022
Aktivomsætning (af bruttofortjeneste)
-3.12×
This company
2022
2022
Gæld/egenkapital
1.61×
This company
0.62×
Market median
-160% vs market
2022
2022
Annual reports & filings
Annual report 2022
Filed via CVR / Virk · Period 2021-11-24 – 2022-12-31
View
PDF
More on Nadavia Pharma ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
